Moderna says FDA refuses to review its application for experimental flu shotModerna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010.{}

Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010.https://www.cnbc.com/2026/02/10/moderna-fda-flu-shot.html